Posters and Happy Hour 2
Tracks
Room 1 | Capitol Ballroom
Room 2 | Crystal A
Room 3 | Crystal B/C
| Friday, June 19, 2026 |
| 16:00 - 18:00 |
Speaker
Dr. Brian Mccrossan
Consultant Paediatric Cardiologist
Royal Belfast Hospital For Sick Children
Obesity and metabolic conditions among adults with Down syndrome
Dr. Courtney Potts
Research Associate
Ulster University
Education, employment and inclusion among young people with Down syndrome: findings from the ‘My Life with Down Syndrome’ study
Dr. Noah Johnson
Assistant Professor
University of Colorado Anschutz Medical Campus
Human APOE4 knock-in modulates behavioral phenotypes of Dp16 mice
Prof. Jeffrey Savas
Associate Professor
Northwestern University, Feinberg School of Medicine
Levetiracetam prevents Aβ42 production through SV2A-dependent modulation of APP processing in Alzheimer’s Disease (AD) models: Hope for putting off Down Syndrome associated AD
Dr. Felipe ten Caten
Instructor
Feinstein Institutes for Medical Research
Mechanisms of Inflammation Across the Lifespan in Individuals with Down Syndrome
Ms. Miranda Pinks
Graduate Research Assistant
Colorado State University
Influence of Mental Age on Modified Checklist for Autism in Toddlers – Revised Scores for Young Children with Down Syndrome
Ms. Mariam Yousuf
Research Associate
Children's Hospital Los Angeles
Delays in the Diagnosis and Blood Pressure Elevations in Moyamoya Vasculopathy in Children with Down Syndrome
Dr. Matthew Zammit
Scientist
University Of Wisconsin-Madison
Cognitive Composites decline earlier in Down Syndrome compared to Neurotypical Adults on the Alzheimer’s Disease biomarker timeline
Dr. Eimear McGlinchey
Assitant Professor In Intellectual Disability
Trinity College
Brain Clocks as Multimodal Markers of Down syndrome Associated Alzheimer’s Disease
Dr. Noemi Spinazzi
Director - Down Syndrome Center of Excellence
Children's Specialized Hospital
Serum and Cerebral Folate Are Normal in Down Syndrome Regression Disorder
Ms. Victoria Ashton
PhD Candidate
Virginia Commonwealth University
Unmasking Trisomy 21-Related Transcriptomic Dysregulation & Enhanced Senescence Using a Mosaic Down Syndrome Model
Mrs Lucia Maure Blesa
Md, Phd Candidate
Unitat Alzheimer Down, Hospital de la Santa Creu i Sant Pau
Epilepsy in Adults with Down syndrome: A Multicentre Clinical Study
Mr. Andre Rocha
PhD Student
University Of Nevada Las Vegas - UNLV
Arterial stiffness and Endothelial Function in Adults with Down syndrome
Ms. Kourtney Sloan
Indiana University Indianapolis
Sex Differences and Periodicity in Down Syndrome-Associated Skeletal Deficits
Dr. Kamla Pillay
Phd Student
Francis Crick Institute
Investigating abnormal haematopoiesis in Down Syndrome (DS) using a mouse mapping panel
Dr. Vanina A Medina
Director
Instituto de Investigaciones Biomédicas (BIOMED, UCA-CONICET)
Clinical and Demographic Characterization of the Argentine Cohort of the Human Trisome Project: A Latin American Contribution to Down Syndrome Research
Ms. Mollie Koester
Undergraduate Student
IU Indianapolis
Post-Maturation Skeletal Phenotypes in Male and Female Mouse Models of Down Syndrome
Mrs Ruixue Cao
Wenzhou Medical University
KCNJ6 inhibits autophagolysosomal degradation of Aβ
Mr Dasoo Yoon
Ph.d. Student
University of Wisconsin-Madison
Trajectories of Cognitive Functioning in Adults with Down syndrome based on Residence
Dr. Orla Megraw
Clinical Research Fellow
Ulster University
Co-occurring medical conditions in people with Down syndrome: evidence from a population-based cohort
Dr. Melissa Parisi
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH INCLUDE Project: Advancing Down Syndrome Research Across the Lifespan
Ms. Dhanalakshmi Srija Chillamcherla
Linda Crnic Institute for Down Syndrome
Systematic multi-omic deconvolution of the clinical heterogeneity of Down syndrome
Dr. Jennifer Maybee
Slpiii, Instructor
Childrens Hospital Colorado
Understanding dysphagia trajectories in children: Use of the Childhood Dysphagia Management Scale (CDMS) to compare time to resolution across children with and without Down syndrome
Dr. Sara Sherman
Postdoctoral Fellow
Linda Crnic Institute for Down syndrome, University of Colorado Anschutz Medical Campus
Differences in arterial resistance responsible for attenuated cardiac output among individuals with Down syndrome during dynamic exercise.
Ms. Miranda Pinks
Graduate Research Assistant
Colorado State University
Associations Between Medical Conditions and Early Development in Toddlers with Down Syndrome
Dr. Tiago Silva Da Silva
Professor
UNIFESP
Designing for Inclusion: The Construction Process of the Rede Buriti SD Observatory
Mr. Samuel Otey
Clinical Research Coordinator
Children's Hospital Los Angeles
Impact of Down Syndrome Regression Disorder on Caregiver Social Networks: A Cross-Sectional Study
Ms. Sabrina Kabakov
Phd Candidate
University Of Wisconsin At Madison
A coordinated web of supports: Collaboration between Down syndrome and childhood cancer organizations
Assistant Professor Elizabeth Will
Assistant Professor
University Of South Carolina
Heart rate variability as a biomarker of feeding-related issues in children with Down syndrome
Mrs. Ana Claudia Brandão
Einstein Hospital Israelita - HTP-LAN
Profile of Co-occurring Conditions in Adults with Down Syndrome in Brazil
Dr. ROSANE LOWENTHAL
Pesquisador
Buriti Network
Down Syndrome Health Map in Brazil: Preliminary Findings from BURITI-DS Network
Mr. Connor Griffiths
Medical Student
University of Florida
Foot Morphology in Adults with Down Syndrome: Evidence of the Need for Better Fitting Shoes
Ms. Letizia Ciafardini
Phdstudent
Sapienza University Of Rome
Defining the mTOR-Dependent Regulation of APP expression in Down Syndrome human and murine models
Ms Kyndal Schade
Research Services Professional
Linda Crnic Institute For Down Syndrome
Triplication of HSA21-encoded genes modulates Alzheimer’s Disease-related phenotypes in vivo via interferon signaling
Dr Stephanie Brown
Senior Research Associate / Aruk Fellow
University Of Camridge
Plasma biomarker profiles and orexin involvement in sleep phenotype and neurodegeneration in Down’s syndrome
Dr. Luciana Fonseca
Assistant Professor
Rutgers University
Amyloid-β, tau PET, and dementia conversion in Down syndrome in relation to intraindividual cognitive variability: relevance to cognitive resilience in a longitudinal cohort study.
Prof. Orestes Forlenza
Full Professor at the Department of Psychiatry, Faculty of Medicine University of Sao Paulo
Buriti-ds Network
Plasma Phospholipid Lipidomics in Aging Adults with Down Syndrome
Professor Weihong Song
Vice President-Academic
Wenzhou Medical University
USP25-Mediated Synaptic Dysfunction, Potential link between DS and AD
Mr. Johnny Boutros
Graduate Student Researcher
University Of California, Irvine
Neurovascular Unit Dysregulation in Down Syndrome Across Cerebral Amyloid Angiopathy Severity
Dr. Isabel Rivera
Postdoctoral Researcher
University Of California, Irvine
Neuropathologic features of Alzheimer’s disease in mosaic Down syndrome
Dr. Jr-Jiun Liou
Research Assistant Professor
University Of Pittsburgh
Antemortem and postmortem white matter hyperintensity and microstructural changes in people with Down syndrome
Dr. Hannah Saternos
Post-doc
Neuron-Derived Extracellular Vesicles Promote Tau Accumulation, Neuroinflammation, and Neurovascular Dysfunction in a Mouse Model of Down syndrome
Ms. Breanna Dooling
CU Anschutz
Apolipoprotein E contributes to Alzheimer’s disease phenotypes in Down syndrome cerebral organoids
Ms. Dolev Michaelovich
PhD student
Bar-Ilan University
Age-Associated Immune Dysregulation and Amyloid-Related Pathology in Down syndrome mice
Dr. Sylvia Perez
Research Associate Professor
Barrow Neurological Institute
Frontal cortex mitochondrial and tau dysfunction in Down syndrome with and without dementia
Dr. Madeleine Healy
Monash University
“Designing and delivering a specialist memory service for individuals with Down syndrome: A qualitative study with people with Down syndrome and their families”
Sra. Aline Conceição
PhD Student
University Of São Paulo
From Balance to Brain: Gait and Postural Control as Functional Markers of Neurodegenerative Staging in Adults with Down Syndrome
Ms. Natalie Edwards
Columbia University
Vascular biomarkers are differentially associated with structural and clinical features of Alzheimer’s disease in adults with Down syndrome
Mr. Carlos Marques
Phd Student
Life and Health Sciences Research Institute (ICVS), School of Medicine, University of Minho
Exploring the use of novel ASOs against Tau in Down Syndrome brain pathology
Dr. Paulina Carriba
Post-doc
Crg, Centre For Genomic Regulation
Down Syndrome Multi omic Profiling Identifies Retrotransposon Mediated Drivers of Neurodegeneration
Dr. Vivek Jain
Assistant Professor
From Natural Compound to Neuroprotective Candidate: Purpurin in Alzheimer’s Disease Research
Prof. Julie Korenberg
Professor
University Of Utah
Trisomy 21 Reverses Immune Pathway Regulation Across Human Cell States
Dr. Xu-Qiao Chen
Project Scientist
University of California San Diego
APP–Rab5–mTOR Signaling Dysregulation in Down Syndrome and Down Syndrome–Associated Alzheimer’s Disease
Dr. Jennifer Bruno
Stanford
White Matter Microstructure in Down Syndrome: Differentiating Developmental Changes from Early Alzheimer's Pathology
Mr Louis Valay
Icm
UNDERSTANDING THE ROLE OF ENDOTHELIAL CELLS IN CEREBRAL AMYLOID ANGIOPATHY IN DOWN SYNDROME AND APP DUPLICATION.
Dr. kanchan chaudhary
Final Year Mbbs Student
National Mortality Trends and Forecasts of Parkinson’s Disease With Psychiatric Comorbidities Among Older Adults in the United States, 1999–2023.
Mrs. Anah Gilmore
Research Services Professional
Neuron-Derived Extracellular Vesicles Modulate Tau Immunoreactivity in Hippocampal Oligodendrocytes in Ts65Dn mice
Ms. Justine A. Silva
PhD Student
University Of California, Irvine (uci)
Linking MRI-defined white matter hyperintensities to postmortem myelin basic protein pathology in Down syndrome–associated Alzheimer’s disease
Dr. Lisi Flores Aguilar
Postdoctoral Scholar
University of California, Irvine
Postmortem characterization of blood–brain barrier breakdown and vascular remodeling across the Alzheimer’s continuum in Down syndrome
Dr. Natalie DiProspero
Postdoctoral Researcher
University Of California, Irvine
Patterns of neurodegeneration due to Alzheimer’s disease track with clinical status and cognition in people with Down syndrome
Ms Fuuko Kammuri
UCL
Exploring Consequences of Interferon Hypersensitivity in Mouse Model of Alzheimer's Disease - Down Syndrome
Ms. Mercedes Lopez
Research Services Professional
University Of Colorado Anschutz
Extracellular Vesicle Interactions with the Blood-Brain Barrier in Alzheimer’s Disease; Mechanistic Insights
PhD Daniella Balduino Victorino
Postdoctoral Research Fellow
Paris Brain Institute - ICM
Comparative analysis of p-tau212 and p-tau217 immunoreactivity in postmortem brain tissue from Down syndrome–associated and sporadic Alzheimer’s disease
Mrs. Lucía Pertierra
Neurologist
Fleni
Plasma P-tau217 diagnostic performance in Down Syndrome-related Alzheimer's Disease (DSAD)
Dr. Carlo Condello
Associate Professor
University Of California, San Francisco
Revealing the conformational heterogeneity of Alzheimer’s disease tau tangles across the lifespan of people with Down syndrome
Dr. Vanessa J R De Paula
Pos Doc
Fmusp
Challenges in generating iPSC lines from individuals with Down syndrome and Alzheimer’s disease
Ms. Neetha Paul Eduthan
Bioinformatics Data Scientist
Linda Crnic Institute For Down Syndrome
Accelerated aging in Down syndrome through hyperactive JAK/STAT signaling
Ms. Lujain Alaali
Phd Candidate
Virginia Commonwealth University
Analysis of Telomere Dysfunction in Isogenic Trisomic and Disomic Cells from People with Mosaic Down Syndrome
Dr. Katharina Alice Patommel
Post-doctoral Research Project Scientist
Francis Crick Institute
Investigation of immunometabolic links between inflammaging and cognitive decline in individuals with trisomy 21
Dr. Jonathan Santoro
Director of Neuroimmunology
Children's Hospital Los Angeles and the Keck School of Medicine of the University of Southern California
Early Detection of Moyamoya Syndrome in Down Syndrome Transcranial Doppler Ultrasound
Dr. Guilherme Prado Mattar
Physician, Msc Candidate In Psychiatry
Universidade de São Paulo
Clinical Validity of the IQCODE-DS for Detecting Cognitive Decline in Adults with Down Syndrome
Dr. Shahid Zaman
Assistant Professor
University Of Cambridge & CPFT
Assessment of individualised regional deviations in brain development in fetuses with Down syndrome using normative modelling of in utero magnetic resonance imaging.
Dr. Natasha Marrus
Associate Professor
Washington University/ibis
White Matter Structural Connectivity Distinguishes Infants with and without Down Syndrome
Mr. Juan Pablo Fraga
research assistant, data manager
Pontificia Universidad Catolica De Chile
Comprehensive Clinical Profile of Comorbidities in Adolescents and Adults with Down Syndrome in Chile: An HTP LAN Network Study
Dr. Kamran Hessami
Resident
Baylor College Of Medicine
Ultrasound findings and birth outcomes among fetuses with Down Syndrome
Ms. Gillian Cook
Cu Anschutz
Plasma Extracellular Vesicles as Biomarkers for Alzheimer’s Disease in Down Syndrome
Dr. Houri Vorperian
Senior Scientist Emerita
University Of Wisconsin-madison
Anatomic Development of Oral and Pharyngeal Structures in Down Syndrome: Implications for Early Intervention to Support the Development of Breathing, Feeding, and Speech
Dr Angelo Carfì
MD
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Beyond switching doctors: the challenge of transitioning from pediatric to adult care in Down syndrome. Multidimensional assessment of functional and psycho-behavioral evolution during a phase of life when everything can change.
Dr. Kelly Sullivan
Assistant Professor
Linda Crnic Institute for Down Syndrome
Analysis of Blood-Based Biomarkers Across the Lifespan in Down Syndrome
Ms. Jenna Thibodeau
Phd Candidate
Wayne State University
Targeting Nucleotide Metabolism to Enhance Ara-C Sensitivity in Myeloid Leukemia Associated with Down syndrome
Dr Laurent Meijer
President & CSO
Perha Pharmaceuticals
Phase 1 clinical trial of Leucettinib-21, a DYRK1A kinase inhibitor aiming at the treatment of Down syndrome, Alzheimer’s disease, and Parkinson’s disease
Ms. Maeve Lucas
Clinical Research Coordinator
Children's Hospital of Los Angeles
Immunosuppression in Down Syndrome Regression Disorder: A Prospective Observational Cohort Study
Ms. Linnea Johnson
Graduate Student
Indiana University Indianapolis
Genetic and Pharmacological Reduction of Dyrk1a/DYRK1A Improves Long Bone Morphology in Ts65Dn Down Syndrome Model Mice
Dr. Roberta Cristelli Fonseca
Postdoctoral Associate
MIT
Maternal multisensory gamma stimulation rescues fetal brain development in a mouse model of Down syndrome
Dr. Jillian Rork
MD
Dartmouth Health
Psoriasis Management in Individuals with Down Syndrome: A Retrospective Cohort Study Using the Epic Cosmos Dataset
Mrs. Nayara Hachich
Phd Student
FAMERP
Thymoquinone as a Potential Therapeutic for Clostridioides difficile Infection in Trisomy 21: Clinical Case and Computational Drug Discovery Analysis
Dr. MD MAHIUDDIN Ahmed
Research Assistant Professor
University of Colorado Anschutz
GM-CSF treatment in mouse models prevents neuronal death in Down Syndrome and reverses behavioral phenotypes and cellular abnormalities in Autism
Dr Marie-claude Potier
Director Of Research Cnrs
Paris Brain Institute, ICM
Blocking toxic Aβ production by targeting the APP cholesterol-binding site
Dr. Sandra Vanegas
Research Associate Professor
University Of Texas At Austin
Landscape of Healthcare Services and Health Disparities among Children with Down Syndrome
Ms. Alyssa Falck
Phd Candidate
Texas A&m University
Prolonged Bone Density Gains After Anabolic PTH Treatment in Male Down Syndrome Mice
Dr. Floriana Costanzo
Bambino Gesù Children's Hospital, Rome
Transcranial direct current stimulation to enhance language and memory in Down syndrome: preliminary preclinical and clinical evidence
Ms. Gautami Bhatt
Research Scholar
Application of Novel Self-assembled Nano-Phosholipid Complex for Improved Therapeutic Effect against HIV-Associated Neurological Disorders (HANDs) Therapy
Dr. Sarah Mann
Physical Therapist
Mann Method Pt And Fitness, Pllc
Process Evaluation of a Remotely Delivered Physical Therapy-Based Exercise Intervention for Adults with Down Syndrome
Dr. Angela Rachubinski
Assistant Research Professor
Linda Crnic Institute for Down Syndrome at the University of Colorado Anschutz
Longitudinal Effects of Tofacitinib in Down Syndrome: A Case Report
Dr. Jessica Hunter
Director, Public Health
RTI International
The INCLUDE (INvestigation of Co-occurring conditions across the Lifespan to Understand Down syndrome) Collaboration for Down Syndrome Progress (CDP)
Prof. Eitan Okun
Vice Dean, The Life Sciences Faculty. Head, The Paul Feder Laboratory For Alzheimer's Disease Research
Bar-Ilan University
An Unbiased Strategy Classification Framework for Quantifying Spatial Cognition in Down Syndrome Models
Ms. Pierrette Lo
Health Informatics Researcher
University of Colorado Anschutz
Incorporating Data Contributor and User Input in Development of the INCLUDE Data Model
Dr. SUTANU NANDI
Post-doctoral Research Fellow
The University of Colorado Anschutz Medical Campus
AI-Augmented Annotation Platform for Trisomy 21 Experimental Model Literature
Dr. Brian Niemeyer
Linda Crnic Institue For Down Syndrome
Advancing Discovery and Impact in Down Syndrome Research with the INCLUDE Down Syndrome Biorepository
Ms. Madelaine Hipp
Research Services Professional
The Linda Crnic Institute For Down Syndrome
Multidimensional biobanking for a pan-omics natural history study of Down syndrome: The Human Trisome Project Biobank
Dr Matthew Galbraith
Associate Research Professor
Linda Crnic Institute For Down Syndrome / University of Colorado Anschutz Medical Campus
The INCLUDE Experimental Models of Down Syndrome Portal
Dr. Sujata Bardhan
Program Director
National Institutes Of Health
Building the Next Generation of Down Syndrome Researchers: NIH INCLUDE Project
Phd Claudia Moreira
Project Coordinator
Alana
Building a National Down Syndrome Research Network Embedded in Community-Based Care and Centralized Operational Governance
Mrs. Daniela Leon Alvarez
Clinical Research Coordinator
Linda Crnic Institute For Down Syndrome
The Human Trisome Project – Latin America Network: Pilot Study Findings
Dr. Stephen Piccolo
Associate Professor
Brigham Young University
Curation and analysis of publicly available, molecular profiles from people with Down Syndrome
Mrs. Laurence Curel
Clinical Research Director Jerome Lejeune Institute
Institut Jérôme Lejeune
BioJeL Biobank : An Evolving Strategy Integrating Deep Phenotyping and Advanced Cellular Models for Down Syndrome
Ms. Caroline A. Lucas
Clinical Research Coordinator
Linda Crnic Institute for Down Syndrome
The Human Trisome Project: A 10-Year Update
Mr. Sanjay Madala
University Of Dayton
An Interactive Web Application for Intervention Evidence Summaries in Preclinical Animal Models of Down Syndrome
Dr. Graciela Moya
Ordinary Proffesor
Pontifical Catholic University Argentina
Building Ethical and Equitable Governance for Down Syndrome Research in Latin America: Lessons from the Human Trisome Project–Latin America (HTP-LAN)
Dr. Laura Ortiz Suarez
Md. Researcher
Unigem
Gaps in healthcare access and social challenges among individuals with Down Syndrome in Colombia
Dr. Jose Francisco Figueroa Perez
Md
Instituto Nacional De Pediatria
Age at Diagnosis of Down Syndrome in Mexico: Timing and Socioeconomic Factors Influencing Early Care Access
MD Macarena Lizama
Associate Professor
Centro UC Síndrome de Down, Pontificia Universidad Catolica de Chile
Nursing Strategies to Optimize the Blood Sampling Experience in Individuals with Down Syndrome
Dr. Gabriela Wagner
Professor
Universidade Federal De São Paulo
Equity and Access to Health Services for People with Down Syndrome in Brazil’s Public Health System
Prof. Luciene Covolan
Professor
Universidade Federal de São Paulo
Assessment of the Social, Educational and Health Characteristics of People with Down Syndrome in Brazil
Dr. Anne Woodruff Jameson
Assistant Professor
UNMC Physical Therapy Education
Vocational Fitness for Transition-Aged Adults with I/DD: Is there a mismatch between current work capacity and desired careers?
Ms. Cecilia Gonzalez
Author
Clínica Alemana Temuco
DOWN SYNDROME AND THE BUSINESS WORLD IN CHILE.
|
